ESTUTC-5 New YorkLog in Sign up

AGMB
AgomAb Therapeutics NV
stockNASDAQADR

At CloseNov 13, 2026 3:59:57 PM EST

6.27USD-0.476%(-0.03)192,639

After-hoursNov 13, 2026 4:00:30 PM EST

6.36USD+1.435%(+0.09)

AGMB News

Day breaks

11:03 AM ESTDirector David Epstein Buys 15,000 Shares of AgomAb Therapeutics NV (AGMB) ·

GuruFocus

11:15 AM EDTFriday 10/23 Insider Buying Report: CLF, AGMB ·

BNK Invest

04:05 PM EDTAgomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease ·

GlobeNewswire Inc.

04:05 PM EDTAgomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation ·

GlobeNewswire Inc.

01:33 PM EDTWednesday 10/7 Insider Buying Report: HRL, AGMB ·

BNK Invest

06:00 PM EDTAgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn's Disease Transcript ·

Seeking Alpha

07:05 AM EDTAgomab Reports Positive STENOVA Data For Ontunisertib ·

RTTNews

06:30 AM EDTAgomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease ·

GlobeNewswire Inc.